Abstract:The graphical abstract highlights how metabolic reprogramming in the tumour microenvironment (TME) suppresses immune responses. Cancer cells enhance glycolysis, depleting key nutrients like glucose and amino acids, which impairs T cell, NK cell and effector immune functions. Concurrently, suppressive metabolites, such as lactate, kynurenine, adenosine and fatty acids, promote immune tolerance, while hypoxia and continuous stimulation exhaust CD8+ T cells, leading to unchecked tumour growth. The result is a TME enriched with immunosuppressive cells (MDSCs, TAMs and Tregs) and fewer effective immune responses, creating a hostile environment for immune‐mediated tumour control. Cancer is a complex and heterogeneous disease characterised by uncontrolled cell growth and proliferation. One hallmark of cancer cells is their ability to undergo metabolic reprogramming, which allows them to sustain their rapid growth and survival. This metabolic reprogramming creates an immunosuppressive microenvironment that facilitates tumour progression and evasion of the immune system. In this article, we review the mechanisms underlying metabolic reprogramming in cancer cells and discuss how these metabolic alterations contribute to the establishment of an immunosuppressive microenvironment. We also explore potential therapeutic strategies targeting metabolic vulnerabilities in cancer cells to enhance immune‐mediated anti‐tumour responses. Trial Registration ClinicalTrials.gov identifier: NCT02044861, NCT03163667, NCT04265534, NCT02071927, NCT02903914, NCT03314935, NCT03361228, NCT03048500, NCT03311308, NCT03800602, NCT04414540, NCT02771626, NCT03994744, NCT03229278, NCT04899921

Molecular Mechanisms Underpinning Immunometabolic Reprogramming: How the Wind Changes during Cancer Progression

Immunometabolic rewiring in tumorigenesis and anti-tumor immunotherapy

Metabolic rewiring and communication in cancer immunity

Metabolic regulation in the immune response to cancer

Immunometabolism in cancer: A journey into innate and adaptive cells

Metabolic Reprogramming in Cancer: Implications for Immunosuppressive Microenvironment

Altered cancer metabolism in mechanisms of immunotherapy resistance

Metabolic reprogramming and immune evasion: the interplay in the tumor microenvironment

Targeting Metabolism to Improve the Tumor Microenvironment for Cancer Immunotherapy

Metabolic Reprogramming of Immune Cells in the Tumor Microenvironment

Immunometabolism in cancer: basic mechanisms and new targeting strategy

Immunological Aspects of Cancer Cell Metabolism

The interplay between metabolic adaptations and diet in cancer immunotherapy

Cancer cell metabolism and antitumour immunity

The cancer metabolic reprogramming and immune response

Cancer immunometabolism: advent, challenges, and perspective

Tumor cell metabolic reprogramming and hypoxic immunosuppression: driving carcinogenesis to metastatic colonization

Emerging Landscapes of Tumor Immunity and Metabolism

Cancer cell metabolic reprogramming: a keystone for the response to immunotherapy

Metabolic Interplay in the Tumor Microenvironment: Implications for Immune Function and Anticancer Response

Tumor Microenvironment-Induced Immunometabolic Reprogramming of Natural Killer Cells